A Preclinical Systematic Review of Ginsenoside-Rg1 in Experimental Parkinson's Disease

To date, no drug has been proven to be neuroprotective or disease-modifying for Parkinson's disease (PD) in clinical trials. Here, we aimed to assess preclinical evidence of Ginsenosides-Rg1 (G-Rg1), a potential neuroprotectant, for experimental PD and its possible mechanisms. Eligible studies...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oxid Med Cell Longev
Main Authors: Song, Liang, Xu, Meng-Bei, Zhou, Xiao-Li, Zhang, Dao-pei, Zhang, Shu-ling, Zheng, Guo-qing
Formato: Artigo
Idioma:Inglês
Publicado em: Hindawi 2017
Assuntos:
Review Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5366755/
https://ncbi.nlm.nih.gov/pubmed/28386306
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2017/2163053
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados